BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12734402)

  • 1. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
    Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
    J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of the SH3 domain in Ca2+-mediated regulation of Src family kinases.
    Monteiro AN
    Biochimie; 2006 Jul; 88(7):905-11. PubMed ID: 16546311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
    Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
    Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Src family kinases in Neu-induced mammary tumors correlates with their association with distinct sets of tyrosine phosphorylated proteins in vivo.
    Muthuswamy SK; Muller WJ
    Oncogene; 1995 Nov; 11(9):1801-10. PubMed ID: 7478608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn.
    Ishino M; Ohba T; Sasaki H; Sasaki T
    Oncogene; 1995 Dec; 11(11):2331-8. PubMed ID: 8570184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement.
    Moarefi I; LaFevre-Bernt M; Sicheri F; Huse M; Lee CH; Kuriyan J; Miller WT
    Nature; 1997 Feb; 385(6617):650-3. PubMed ID: 9024665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
    Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
    Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yes-associated protein (YAP65) is a proline-rich phosphoprotein that binds to the SH3 domain of the Yes proto-oncogene product.
    Sudol M
    Oncogene; 1994 Aug; 9(8):2145-52. PubMed ID: 8035999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Yes response to growth factor activation.
    Clump DA; Qazi IH; Sudol M; Flynn DC
    Growth Factors; 2005 Dec; 23(4):263-72. PubMed ID: 16338789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intrinsic ability of AFAP-110 to alter actin filament integrity is linked with its ability to also activate cellular tyrosine kinases.
    Baisden JM; Gatesman AS; Cherezova L; Jiang BH; Flynn DC
    Oncogene; 2001 Oct; 20(45):6607-16. PubMed ID: 11641786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src can regulate carboxy terminal interactions with AFAP-110, which influence self-association, cell localization and actin filament integrity.
    Qian Y; Baisden JM; Westin EH; Guappone AC; Koay TC; Flynn DC
    Oncogene; 1998 Apr; 16(17):2185-95. PubMed ID: 9619827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical localization of protein kinases Yes and Src in amoeboid microglia in culture: association of Yes kinase with vimentin intermediate filaments.
    Ciesielski-Treska J; Ulrich G; Chasserot-Golaz S; Aunis D
    Eur J Cell Biol; 1995 Dec; 68(4):369-76. PubMed ID: 8690016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric constructs containing the SH4/Unique domains of cYes can restrict the ability of Src(527F) to upregulate heme oxygenase-1 expression efficiently.
    Hoey JG; Summy J; Flynn DC
    Cell Signal; 2000 Oct; 12(9-10):691-701. PubMed ID: 11080622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active recombinant human tyrosine kinase c-Yes: expression in baculovirus system, purification, comparison to c-Src, and inhibition by a c-Src inhibitor.
    Susa M; Luong-Nguyen NH; Crespo J; Maier R; Missbach M; McMaster G
    Protein Expr Purif; 2000 Jun; 19(1):99-106. PubMed ID: 10833396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An SH2-domain-containing kinase negatively regulates the phosphatidylinositol-3 kinase pathway.
    Moniakis J; Funamoto S; Fukuzawa M; Meisenhelder J; Araki T; Abe T; Meili R; Hunter T; Williams J; Firtel RA
    Genes Dev; 2001 Mar; 15(6):687-98. PubMed ID: 11274054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Src-family kinases in formation of the cortical actin cap at the dorsal cell surface.
    Kuga T; Hoshino M; Nakayama Y; Kasahara K; Ikeda K; Obata Y; Takahashi A; Higashiyama Y; Fukumoto Y; Yamaguchi N
    Exp Cell Res; 2008 Jun; 314(10):2040-54. PubMed ID: 18457834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation.
    Sun G; Sharma AK; Budde RJ
    Oncogene; 1998 Sep; 17(12):1587-95. PubMed ID: 9794236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SH2 domain-mediated activation of an SRC family kinase is not required to initiate Ca2+ release at fertilization in mouse eggs.
    Mehlmann LM; Jaffe LA
    Reproduction; 2005 May; 129(5):557-64. PubMed ID: 15855619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the non-catalytic domains of Fyn and Fgr tyrosine kinases reveal differences in mechanisms of their regulation.
    Rivero-Lezcano OM; Marcilla A; Robbins KC
    Oncogene; 1995 Dec; 11(12):2675-9. PubMed ID: 8545125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.